MOG and encephalomyelitis: Another newly discovered biomarker is the anti-MOG antibody found in the CSF of patients with demyelinating diseases such as optic neuritis (usually recurrent), myelitis encephalitis, brainstem encephalitis, and acute disseminated encephalomyelitis (ADEM)-like presentations.